LeanTaaS, founded in 2010, develops AI-powered capacity management software for the healthcare sector. Its core platform, iQueue, applies predictive analytics, machine learning, and lean principles to help hospitals unlock existing operational capacity. The company reports that its solutions generate an additional $100,000 in revenue per operating room annually, a 6% increase in surgical case volume, $20,000 per infusion chair, and $10,000 per inpatient bed each year.
The firm's technology is deployed across more than 190 health systems and over 1,200 hospitals and centers in 49 states. Its iQueue for Infusion Centers product covers more than 20% of all infusion chairs in the United States, with notable adoption among top cancer treatment facilities: 57 of the top 100 cancer hospitals, 80% of National Comprehensive Cancer Network members, and nearly 60% of National Cancer Institute-Designated Cancer Centers use the platform. Seventy percent of hospitals on the U.S. News & World Report Honor Roll are also served.
The company has received significant financial backing, including a $130 million funding round led by Insight Partners and Goldman Sachs, alongside a growth investment from Bain Capital. LeanTaaS has been named Best in KLAS for Capacity Optimization Management for consecutive years. Its technical work spans AI-powered capacity management, predictive analytics, and machine learning.
